Plasma concentrations of dasatinib have a clinical impact on the frequency of dasatinib dose reduction and interruption in chronic myeloid leukemia: an analysis of the DARIA 01 study.

Int J Clin Oncol · 2018 · PMC6154123 · PMID 29845477

Europe PMC DOI

hedged sentence

0.1864

closest p · 3.7× alpha

0.1864

boldest claim

The sentences

did not reach statistical significancep = 0.1864not close (p > 0.1)

The incidence of PE by 12 months in high age (≥ 60) group was higher than that in low age (< 60) group, but did not reach statistical significance (40% vs. 18%, p = 0.1864).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.